DK1579859T3 - Anvendelse af N-(2-arylpropionyl)-sulfonamider til behandling af rygmarvsskader - Google Patents

Anvendelse af N-(2-arylpropionyl)-sulfonamider til behandling af rygmarvsskader

Info

Publication number
DK1579859T3
DK1579859T3 DK04007177T DK04007177T DK1579859T3 DK 1579859 T3 DK1579859 T3 DK 1579859T3 DK 04007177 T DK04007177 T DK 04007177T DK 04007177 T DK04007177 T DK 04007177T DK 1579859 T3 DK1579859 T3 DK 1579859T3
Authority
DK
Denmark
Prior art keywords
sulfonamides
spinal cord
cord injury
arylpropionyl
treat spinal
Prior art date
Application number
DK04007177T
Other languages
English (en)
Inventor
Riccardo Bertini
Francesco Colotta
Original Assignee
Dompe Pha R Ma Spa Res & Mfg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dompe Pha R Ma Spa Res & Mfg filed Critical Dompe Pha R Ma Spa Res & Mfg
Application granted granted Critical
Publication of DK1579859T3 publication Critical patent/DK1579859T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/4035—Isoindoles, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK04007177T 2004-03-25 2004-03-25 Anvendelse af N-(2-arylpropionyl)-sulfonamider til behandling af rygmarvsskader DK1579859T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04007177A EP1579859B1 (en) 2004-03-25 2004-03-25 Use of N-(2-aryl-propionyl)-sulfonamides for the treatment of spinal cord injury

Publications (1)

Publication Number Publication Date
DK1579859T3 true DK1579859T3 (da) 2007-04-10

Family

ID=34854609

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04007177T DK1579859T3 (da) 2004-03-25 2004-03-25 Anvendelse af N-(2-arylpropionyl)-sulfonamider til behandling af rygmarvsskader

Country Status (23)

Country Link
US (1) US20090030083A1 (da)
EP (1) EP1579859B1 (da)
JP (1) JP4988550B2 (da)
KR (2) KR101312235B1 (da)
CN (2) CN103054842A (da)
AT (1) ATE347883T1 (da)
AU (1) AU2005226901B2 (da)
BR (1) BRPI0509167A (da)
CA (1) CA2555162C (da)
CY (1) CY1107562T1 (da)
DE (1) DE602004003673T2 (da)
DK (1) DK1579859T3 (da)
ES (1) ES2279248T3 (da)
IL (1) IL177169A (da)
MX (1) MXPA06009085A (da)
NO (1) NO20064793L (da)
NZ (1) NZ548917A (da)
PL (1) PL1579859T3 (da)
PT (1) PT1579859E (da)
RU (1) RU2396075C2 (da)
SI (1) SI1579859T1 (da)
WO (1) WO2005092315A1 (da)
ZA (1) ZA200608517B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2066335A4 (en) * 2006-09-26 2010-01-20 Univ Case Western Reserve CYTOKINE SIGNALING
EP2308485A1 (en) 2009-10-06 2011-04-13 Dompé S.p.a. Sulfonamides for the prevention of diabetes
EP2308484A1 (en) 2009-10-06 2011-04-13 Dompé S.p.a. Inhibitors of cxcr1/2 as adjuvants in the transplant of pancreatic islets
CN103172547B (zh) * 2011-12-20 2016-10-12 天津市国际生物医药联合研究院 磺酰胺衍生物的制备及其应用
CN103159674A (zh) * 2013-04-03 2013-06-19 苏州安诺生物医药技术有限公司 2-苯烷酰胺类化合物及其制备方法、药物组合物和用途
KR20220064039A (ko) 2020-11-11 2022-05-18 정성삼 척수 손상 예방 또는 치료용 조성물
KR102320780B1 (ko) 2021-01-29 2021-11-02 정성삼 척추 통증 완화 및 척추 유연성 개선을 위한 조성물 및 이의 제조방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1303249B1 (it) * 1998-10-23 2000-11-06 Dompe Spa Alcune n-(2-aril-propionil)-solfonammidi e preparazionifarmaceutiche che le contengono.
US6419944B2 (en) * 1999-02-24 2002-07-16 Edward L. Tobinick Cytokine antagonists for the treatment of localized disorders
IT1318466B1 (it) * 2000-04-14 2003-08-25 Dompe Spa Ammidi di acidi r-2-(amminoaril)-propionici, utili nella prevenzionedell'attivazione leucocitaria.
ITMI20010206A1 (it) * 2001-02-02 2002-08-02 Dompe Spa Uso della metansolfonammide di (r)-ibuprofene e dei suoi sali non tossici per la preparazione di medicamenti per il trattamento e la prevenz

Also Published As

Publication number Publication date
WO2005092315A1 (en) 2005-10-06
KR101327150B1 (ko) 2013-11-06
CN103054842A (zh) 2013-04-24
SI1579859T1 (sl) 2007-04-30
DE602004003673D1 (de) 2007-01-25
US20090030083A1 (en) 2009-01-29
AU2005226901A1 (en) 2005-10-06
ATE347883T1 (de) 2007-01-15
KR20070018015A (ko) 2007-02-13
NO20064793L (no) 2006-10-23
DE602004003673T2 (de) 2007-10-04
ZA200608517B (en) 2008-04-30
EP1579859A1 (en) 2005-09-28
CY1107562T1 (el) 2013-03-13
CA2555162A1 (en) 2005-10-06
IL177169A0 (en) 2006-12-10
CN1933825A (zh) 2007-03-21
PL1579859T3 (pl) 2007-06-29
IL177169A (en) 2010-12-30
JP4988550B2 (ja) 2012-08-01
RU2006137575A (ru) 2008-04-27
ES2279248T3 (es) 2007-08-16
NZ548917A (en) 2010-06-25
MXPA06009085A (es) 2007-04-02
KR20120104445A (ko) 2012-09-20
KR101312235B1 (ko) 2013-09-26
JP2007530478A (ja) 2007-11-01
BRPI0509167A (pt) 2007-09-11
AU2005226901B2 (en) 2011-06-02
RU2396075C2 (ru) 2010-08-10
CA2555162C (en) 2012-11-27
EP1579859B1 (en) 2006-12-13
PT1579859E (pt) 2007-03-30

Similar Documents

Publication Publication Date Title
EA200870446A1 (ru) Пиридон сульфонамиды и пиридон сульфамиды в качестве ингибиторов мек
EA201070422A1 (ru) Производные оксадиазола
EA200701396A1 (ru) Триазолофталазины в качестве ингибиторов pde-2
EA200601587A1 (ru) Новые амидозамещённые гидрокси-6-фенилфенантридины
EA201000494A1 (ru) Новые гидрокси-8-гетероарилфенантридины и их применение в качестве ингибиторов pde4
ATE517896T1 (de) P38-kinase-inhibitoren
EA200802213A1 (ru) Способы лечения заболеваний крови
EA200701840A1 (ru) N-сульфонилпирролы и их применение в качестве ингибиторов гистондезацетилазы
EA200700400A1 (ru) Производные n-(1h-индолил)-1н-индол-2-карбоксамидов, их получение и их применение в терапии
EA200700717A1 (ru) Сульфонамиды
EA201000550A1 (ru) Производные тиазола
NO20055563L (no) Midler for behandlingen av lavere abdominale lidelser
EA200700702A1 (ru) Аналоги локсапина и способы их применения
NO20055741L (no) Nye kjemiske forbindelser
EA200801351A1 (ru) Фунгицидные смеси, которые содержат боскалид и пириметанил
EA200870515A1 (ru) Моноциклические гетероарильные соединения
EA200602281A1 (ru) Гетероарилсульфоны и сульфонамиды и их терапевтические применения
EA201070009A1 (ru) Производные 7-алкинил-1,8-нафтиридонов, их получение и их применение в терапии
NO20064793L (no) Anvendelse av N-(2-arylpropionyl) sulfonamider for behandling av ryggmargskade.
EA200601855A1 (ru) Гербицидоактивные 3-амино-2-тиометилбензоилпиразолы
EA201000618A1 (ru) 5-цианотиенопиридины для лечения опухолей
ATE396970T1 (de) 2-(1h-indolylsulfanyl)-benzylaminderivate als ssri
EA200602180A1 (ru) Производные 2-(1h-индолилсульфанил)ариламина для применения при лечении аффективных расстройств, боли, нгдв и стрессового недержания мочи
ATE526970T1 (de) Behandlung von mastitis
EA200602154A1 (ru) Пиридин-4-илэтинилимидазолы и -пиразолы как антагонисты рецептора mglu5